Franklin Resources Inc. trimmed its position in shares of Cigna Group (NYSE:CI – Free Report) by 19.3% during the 4th quarter, Holdings Channel reports. The fund owned 503,370 shares of the health services provider’s stock after selling 120,623 shares during the period. Franklin Resources Inc.’s holdings in Cigna Group were worth $138,543,000 at the end of the most recent reporting period.
Other hedge funds have also modified their holdings of the company. Beacon Financial Strategies CORP purchased a new stake in shares of Cigna Group during the 4th quarter worth approximately $28,000. Lodestone Wealth Management LLC purchased a new stake in shares of Cigna Group during the 4th quarter worth approximately $32,000. Creative Financial Designs Inc. ADV raised its holdings in shares of Cigna Group by 147.3% during the 4th quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock worth $37,000 after acquiring an additional 81 shares in the last quarter. Activest Wealth Management raised its holdings in shares of Cigna Group by 1,050.0% during the 4th quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock worth $38,000 after acquiring an additional 126 shares in the last quarter. Finally, Entrust Financial LLC purchased a new stake in shares of Cigna Group during the 4th quarter worth approximately $42,000. 86.99% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several analysts have recently issued reports on CI shares. Barclays cut Cigna Group from an “overweight” rating to an “equal weight” rating and decreased their price objective for the stock from $310.00 to $304.00 in a report on Tuesday, May 26th. Raymond James Financial set a $340.00 price objective on Cigna Group in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft downgraded Cigna Group from a “buy” rating to a “hold” rating and cut their target price for the company from $303.00 to $302.00 in a research report on Wednesday, May 20th. Jefferies Financial Group cut their target price on Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a research report on Monday, April 20th. Finally, Cantor Fitzgerald boosted their target price on Cigna Group from $325.00 to $340.00 and gave the company an “overweight” rating in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $338.80.
Cigna Group Stock Performance
NYSE CI opened at $296.34 on Thursday. The company has a market cap of $78.39 billion, a P/E ratio of 12.56, a P/E/G ratio of 1.14 and a beta of 0.28. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The business’s 50 day moving average price is $281.36 and its 200-day moving average price is $277.76. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $338.89.
Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating the consensus estimate of $7.60 by $0.19. The company had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.Cigna Group’s quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Sell-side analysts predict that Cigna Group will post 30.39 earnings per share for the current year.
Cigna Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be given a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s dividend payout ratio is 26.45%.
Insider Buying and Selling
In other Cigna Group news, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This represents a 85.46% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by company insiders.
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Stories
- Five stocks we like better than Cigna Group
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
